American Journal of Cardiology
Volume 100, Issue 6 , Pages 949-952 , 15 September 2007

Safety of Drug-Eluting Stents in the Coronary Artery in ST-Elevation Myocardial Infarction at a Single High-Volume Medical Center

Received 27 February 2007 ,Revised 10 April 2007 ,Accepted 10 April 2007.

References 

  1. Laarman GJ, Suttorp MJ, Dirksen MT, van Heerebeek L, Kiemeneij F, Slagboom T, et al. Paclitaxel-eluting versus uncoated stents in primary percutaneous coronary intervention. N Engl J Med. 2006;355:1105–1113
  2. Spaulding C, Henry P, Teiger E, Beatt K, Bramucci E, Carrie D, et al Sirolimus-eluting versus uncoated stents in acute myocardial infarction. N Engl J Med. 2006;355:1093–1104
  3. Menichelli M, Parma A, Pucci E, Fiorilli R, Felice FD, Nazzaro M, et al. Randomized trial of sirolimus-eluting stent versus bare-metal stent in acute myocardial infarction (SESAMI). J Am Coll Cardiol. 2007;49:1924–1930
  4. Park DW, Park SW, Park KH, Lee BK, Kim YH, Lee CW, et al. Frequency of and risk factors for stent thrombosis after drug-eluting stent implantation during long-term follow-up. Am J Cardiol. 2006;98:352–356
  5. Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi G, Stankovic G, et al Incidence, predictors and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA. 2005;293:2126–2130
  6. Hofma S, Ong A, Aoki J, Van Mieghem C, Granillo G, Vaglimigli M, et al One year clinical follow up of paclitaxel eluting stents for acute myocardial infarction compared with sirolimus eluting stents. Heart. 2005;91:1176–1180
  7. Stone GW, Ellis SG, Cox DA, Hermiller J, O’Shaughnessy C, Mann J, et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med. 2004;350:221–231
  8. Moses J, Leon M, Popma JJ, Fitzgerald PJ, Holmes D, O’Shaughnessy C, et al. Sirolumus-eluting stents versus standard stents in patients with stenosis in native coronary artery. N Engl J Med. 2003;349:1315–1323
  9. Park SJ, Shim WH, Ho DS, Raizner AE, Park SW, Hong M, et al. A paclictaxel stent for the prevention of coronary restenosis. N Engl J Med. 2003;348:1537–1545
  10. Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med. 2002;346:1773–1780
  11. Pasceri V, Granatelli A, Pristipino C, Pelliccia F, Speciale G, Pironi B, et al. A randomized trial of rapamycin-eluting stent in acute myocardial infarction: preliminary results. Am J Cardiol. 2003;92(suppl 1):1;(abstr)
  12. Regar E, Lemos P, Saia F, Degerteckia M, Tanabe K, Lee C, et al Incidence of thrombotic stent occlusion during the first three months after sirolimus-eluting stent implantation in 500 consecutive patients. Am J Cardiol. 2004;93:1271–1275
  13. Ong A, Hoye A, Aoki J, Van Mieghem C, Granillo G, Sonnenschein K, et al Thirty-day incidence and six-month clinical outcome of thrombotic stent occlusion after bare-metal, sirolimus, or paclitaxel stent implantation. J Am Coll Cardiol. 2005;45:947–953

PII: S0002-9149(07)01130-7

doi: 10.1016/j.amjcard.2007.04.030

American Journal of Cardiology
Volume 100, Issue 6 , Pages 949-952 , 15 September 2007

Article Tools